Procter & Gamble
PG
$145.71
+2.00%
The Procter & Gamble Company is a global leader in the consumer defensive sector, manufacturing and selling a vast portfolio of household and personal care products, including iconic brands like Tide, Pampers, Charmin, and Pantene. It operates as a dominant market leader with immense scale, brand equity, and a global distribution network that spans over 180 countries. The current investor narrative centers on its resilience as a defensive, dividend aristocrat amid market volatility, with debates focusing on its ability to sustain organic growth and expand margins in the face of persistent cost inflation and competitive pressures, as highlighted by recent analyst actions and coverage emphasizing its long-term dividend growth story.…
PG
Procter & Gamble
$145.71
Related headlines
PG 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $189.42 and implied upside of +30.0% versus the current price.
Average Target
$189.42
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$117 - $189
Analyst target range
Insufficient analyst coverage data is available in the provided dataset to calculate a precise consensus target price, Buy/Hold/Sell distribution, or implied upside. The limited data point of 7 analysts providing estimates suggests this mega-cap stock likely has broader coverage that is not captured here. The absence of this key consensus data means investors lack a clear benchmark for institutional price expectations, which can contribute to higher volatility and less efficient price discovery despite the company's size and prominence. The available institutional ratings show a mixed but generally stable sentiment, with recent actions including a downgrade from TD Cowen (Buy to Hold) in January 2026 and an upgrade from JP Morgan (Neutral to Overweight) the same month, indicating ongoing debate about near-term prospects amidst the stock's weak price performance.
PG Technical Analysis
The stock is in a pronounced downtrend, having declined 13.89% over the past year, significantly underperforming the S&P 500's 34.9% gain, as evidenced by a relative strength reading of -48.79. Currently trading at $146.93, it sits at approximately 86% of its 52-week range, positioned closer to the 52-week low of $137.62 than the high of $170.99, suggesting the stock is in a value-seeking zone but remains under significant selling pressure. Recent momentum shows a stark divergence, with the stock up a mere 0.15% over the past month against a strong 7.36% rally in the S&P 500, indicating a severe lack of participation in the broader market's advance and highlighting its defensive, low-beta characteristics. Key technical support is clearly defined at the 52-week low of $137.62, while resistance looms near the recent highs around $167.20; a sustained break below support could signal a deeper capitulation, while reclaiming the $160 level is necessary to suggest a trend reversal. The stock's beta of 0.403 confirms its status as a low-volatility defensive holding, being roughly 60% less volatile than the market, which is a critical consideration for risk-averse portfolios seeking stability over aggressive growth.
Beta
0.40
0.40x market volatility
Max Drawdown
-19.9%
Largest decline past year
52-Week Range
$138-$171
Price range past year
Annual Return
-12.1%
Cumulative gain past year
| Period | PG Return | S&P 500 |
|---|---|---|
| 1m | +1.8% | +8.5% |
| 3m | -3.0% | +2.8% |
| 6m | -4.4% | +4.6% |
| 1y | -12.1% | +32.3% |
| ytd | +2.8% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PG Fundamental Analysis
Revenue growth is stable but modest, with the most recent quarterly revenue of $22.21 billion representing a 1.49% year-over-year increase; however, sequential trends show a slight decline from the prior quarter's $22.39 billion, indicating a potential plateau in top-line momentum. The company remains highly profitable, posting net income of $4.33 billion in Q2 2026 and maintaining robust gross and operating margins of 51.16% and 24.16%, respectively, though these margins have compressed slightly from the 51.37% gross margin and 26.16% operating margin reported in the previous quarter. Financial health is exceptionally strong, evidenced by a manageable debt-to-equity ratio of 0.68, a stellar return on equity of 30.71%, and substantial free cash flow generation of $14.85 billion on a trailing twelve-month basis, which amply covers the dividend and share repurchases, providing significant financial flexibility and resilience.
Quarterly Revenue
$22.2B
2025-12
Revenue YoY Growth
+0.01%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$14.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PG Overvalued?
Given its consistent profitability, the primary valuation metric is the P/E ratio. The stock trades at a trailing P/E of 24.48x and a forward P/E of 20.28x. The forward multiple's discount to the trailing figure implies the market expects modest earnings growth, aligning with the company's stable but slow-growth profile. Compared to sector averages, P&G's valuation commands a significant premium. Its trailing P/E of 24.48x and Price/Sales of 4.64x are well above typical consumer staples averages, which often range in the high-teens for P/E. This premium is justified by the company's superior brand portfolio, pricing power, and industry-leading profitability, as reflected in its net margin of 18.95%. Historically, the current trailing P/E of 24.48x is below its own recent peak observed in mid-2025 (over 27x) but remains above levels seen in late 2023 and early 2024 (around 19-22x). This positioning suggests the stock is not at bargain-basement historical levels but has de-rated from recent highs, potentially offering a more reasonable entry point within its own historical context for a quality compounder.
PE
24.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 19x~32x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.4x
Enterprise Value Multiple
